Figure 6

Overall survival of the pemetrexed/cisplatin and gemcitabine/cisplatin arms stratified by tumor FDG uptake in (A) the TS-negative group and (B) the TS-positive group. TS, thymidylate synthase; FDG, 18F-fluorodeoxyglucose.

Overall survival of the pemetrexed/cisplatin and gemcitabine/cisplatin arms stratified by tumor FDG uptake in (A) the TS-negative group and (B) the TS-positive group. TS, thymidylate synthase; FDG, 18F-fluorodeoxyglucose.